Bayer hit by failure to cap risk from weedkiller cases By Reuters
By Ludwig Burger FRANKFURT (Reuters) -Bayer shares dropped as much as 5% on Thursday after a U.S. judge rejected its plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer. The German group called into question the future sale of glyphosate-based products to residential users in the U.S., and said it would review plans to settle around 30,000 legal claims, after the judge called Bayer (DE:BAYGN)'s plan to end years of litigation "unreasonable" on Wednesday. "We will continue to assess financial risks as we move forward," finance chief...
Подробнее